Skip to main content
. 2009 Feb 17;3(2):e383. doi: 10.1371/journal.pntd.0000383

Table 2. ECG findings at baseline, by disease stage compared to healthy subjects.

Healthy controls HAT stage 1 HAT stage 2 p-value
N = 61 N = 406 N = 56
ECG Intervals (msec; mean (SD))
PQ 163 (16) 159 (24) 169 (25) 0.008γ
QRS 82 (11) 80 (9) 82 (8) 0.076
QTc 403 (21) 421 (28) 423 (25) <0.001α β
ECG Findings (%)
atrial fibrillation/flutter 0.0 0.3 0.0 0.862
premature atrial capture 1.6 0.5 0.0 0.450
premature ventricular capture 1.6 0.7 3.6 0.285
bigeminus 0.0 0.2 0.0 0.871
AV block 1 3.3 3.7 7.1 0.449
AV block 2 0.0 0.0 0.0 1.000
RAH (Right atrial hypertrophy) 0.0 1.7 1.8 0.334
LAH (Left atrial hypertrophy) 1.6 2.5 5.4 0.394
RVH (Right ventricular hypertrophy) 3.3 5.2 3.6 0.732
LVH (Left ventricular hypertrophy) 1.6 2.0 1.7 0.977
pathologic Q 0.0 1.0 0.0 0.551
RBBB (Right bundle brunch block) 0.0 1.0 0.0 0.581
LBBB (Left bundle brunch block) 1.6 0.0 0.0 0.011
LAHB (Left anterior hemiblock) 1.6 1.7 0.0 0.584
RBBB and LAHB 0.0 0.5 1.7 0.469
repolarisation changes 6.6 35.2 32.1 <0.001α β
low voltage 6.7 20.0 30.4 0.005α β γ
QTc prolongationa 0 11.1 12.5 0.021α β
minor changes 16.4 9.6 7.1 0.193
major changes 19.7 53.5 67.9 <0.001α β γ
a

for male >440 msec, female >460 msec

α: for healthy control vs HATstage 1 p<0.05

β: for healthy control vs HATstage 2 p<0.05

γ: for HAT stage 1 vs HATstage 2 p<0.05